Not So Illuminated
I really like following the life-sciences-instruments companies because of the dense technical jargon, as well as the spectacular flameouts that happen like clockwork. Take Illumina (ILMN), for example. The stock has dropped 44% since mid July on "conservative" guidance and fears over government budget cuts. On Monday the company presented at the UBS Global Life Science Conference and tried to talk the stock (back) up.
Illumina is a maker of genetic-analysis tools and related consumables. Its machines are fantastically cutting edge and phenomenally expensive -- all the elements you need for a volatile stock. (If you like following the semiconductor equipment space, you'll love following this industry!)...619 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.